Comprehensive discussion with docs ups cancer screening

Comprehensive discussion with docs ups cancer screening
Having more comprehensive discussions about colorectal cancer screening with primary care providers is associated with increased odds of screening, according to a study published in the April issue of the American Journal of Managed Care.

(HealthDay)—Having more comprehensive discussions about colorectal cancer (CRC) screening with primary care providers (PCPs) is associated with increased odds of screening, according to a study published in the April issue of the American Journal of Managed Care.

David M. Mosen, Ph.D., M.P.H., from Kaiser Permanente Northwest in Portland, Ore., and colleagues examined the between the comprehensiveness of CRC screening discussion by PCPs and the completion of screening in a observational study involving 883 participants overdue for CRC screening. Of the 249 participants who completed screening, 84 percent were surveyed about their PCPs' discussion of CRC screening and patient beliefs pertaining to screening.

The researchers found that the average score for comprehensiveness of CRC discussion was 0.4 (range 0 to 1) and the average score for perceived benefits of screening was 4.0 (range 1 to 5). Almost all completed the fecal immunochemical test (95.2 percent). The odds of screening were significantly increased with more comprehensive discussion of CRC screening (odds ratio [OR], 1.51). Increased screening was also associated with higher perceived benefits (OR, 1.46) and with one or more PCP visits (OR, 5.82).

"We found that patients' self-report of more comprehensive discussion of CRC screening by PCPs and a greater perceived level of benefit were independently associated with receipt of CRC screening," the authors write. "This suggests that CRC screening efforts may be usefully directed toward increasing the intensity of screening discussion by PCPs and other care providers."

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

Nov 21, 2014

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

Nov 21, 2014

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.